Viva Biotech Holdings ( (HK:1873) ) has issued an announcement.
Viva Biotech Holdings has announced its upcoming annual general meeting scheduled for June 12, 2025, in Shanghai, where key resolutions will be discussed. These include the adoption of financial statements, re-election of directors, and authorization for the board to fix directors’ remuneration and appoint auditors. The meeting will also consider authorizing the directors to issue additional shares, which could impact the company’s capital structure and market positioning.
More about Viva Biotech Holdings
Viva Biotech Holdings is a company incorporated in the Cayman Islands, operating in the biotechnology industry. It focuses on providing drug discovery services and is listed on the Hong Kong Stock Exchange.
YTD Price Performance: 74.42%
Average Trading Volume: 9,603,814
Technical Sentiment Signal: Sell
Current Market Cap: HK$3.05B
For detailed information about 1873 stock, go to TipRanks’ Stock Analysis page.